Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A multiplex UPLC-MS/MS method for the quantification of three PD-L1 checkpoint inhibitors, atezolizumab, avelumab, and durvalumab, in human serum.
J Pharm Biomed Anal. 2024 Jun 15;243:116108. doi: 10.1016/j.jpba.2024.116108. Epub 2024 Mar 16.
J Pharm Biomed Anal. 2024.
PMID: 38522382
Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.
Baarslag MA, Heimovaara JH, Borgers JSW, van Aerde KJ, Koenen HJPM, Smeets RL, Buitelaar PLM, Pluim D, Vos S, Henriet SSV, de Groot JWB, van Grotel M, Rosing H, Beijnen JH, Huitema ADR, Haanen JBAG, Amant F, Gierenz N.
Baarslag MA, et al. Among authors: buitelaar plm.
N Engl J Med. 2023 Nov 9;389(19):1790-1796. doi: 10.1056/NEJMoa2308135.
N Engl J Med. 2023.
PMID: 37937778
Item in Clipboard
ELISA assay for the quantification of ipilimumab in human serum, plasma, milk, and cerebrospinal fluid.
Pluim D, Buitelaar P, de Jong KAM, Rosing H, Brandsma D, Huitema ADR, Beijnen JH.
Pluim D, et al.
J Pharm Biomed Anal. 2024 Aug 1;245:116140. doi: 10.1016/j.jpba.2024.116140. Epub 2024 Apr 8.
J Pharm Biomed Anal. 2024.
PMID: 38701533
Item in Clipboard
Cite
Cite